8 breakthrough monoclonal antibody protocols reshaping autoimmune care in 2026
As 2026 unfolds, the global medical community is witnessing a decisive pivot toward ultra-targeted monoclonal antibodies that promise to halt tissue degradation before clinical symptoms manifest. This transition is being fueled by new guidelines from the Indian Ministry of Health and Family Welfare, which prioritize early-stage intervention for rheumatoid arthritis and multiple sclerosis. By...
0 Comentários 0 Compartilhamentos 29 Visualizações 0 Anterior